Boston Scientific announces agreement to acquire Claret Medical for $270 milllion
Boston Scientific announced an agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel® Cerebral Embolic Protection System. The transaction price consists of $220 million in cash, and milestone payment of up to $50 million. July 20, 2018